Sign in to view content

Outcomes of Antivascular Endothelial Growth Factor (VEGF) Therapy for Neovascular Age-Related Macular Degeneration in Routine Clinical Practice

Andrew A. Moshfeghi, MD, MBA, FASRS

Video
Published 2018

Related

To Treat or Not to Treat: Are We Sacrificing Treatment Outcomes by Allowing Diabetic Retinopathy (DR) to Enter the Proliferative Stage?
Michael J. Elman, MD
Annual Meeting Talks
2018
3-Year Update for the Phase 3 Voretigene Neparvovec-rzyl Study in Biallelic RPE65 Mutation-Associated Inherited Retinal Disease
Stephen R. Russell, MD
Annual Meeting Talks
2018
Comparative Study of Inverted ILM Flap and PRP as an Adjunct in Large Macular Holes
Naresh Babu Kannan, MS, FNB(V R),MBA (H R),FASRS,.
Annual Meeting Talks
2018

Category: Age-Related Macular Degeneration

See more